Literature DB >> 17330304

Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus.

Christina A Boros1, Dawn Spence, Susan Blaser, Earl D Silverman.   

Abstract

OBJECTIVE: Neurologic involvement has been reported to occur in infants with neonatal lupus erythematosus (NLE), although the significance of these findings is unknown. The purpose of this study was to determine if hydrocephalus/macrocephaly is a manifestation of NLE.
METHODS: Infants from the Hospital for Sick Children in Toronto, Canada whose mothers had anti-Ro antibodies were followed prospectively. A total of 87 infants were seen in the study period (1999-2004). The maternal autoantibody status of all infants was documented, and all infants underwent full clinical examination at each visit.
RESULTS: Of the 87 infants, 47 had NLE. Five of the 47 infants with NLE and 2 of the healthy infants had hydrocephalus, resulting in a prevalence of 8.0% (95% confidence interval 4.0-15.0%) in the entire cohort. This is significantly higher than the prevalence in the general population of 0.048-0.081%. Head circumference measurements of infants in the Toronto cohort were largest between 12-24 months of age (Z score difference = 0.71, P = 0.008).
CONCLUSION: We suggest that hydrocephalus and macrocephaly are manifestations of NLE and that infants born to mothers with anti-Ro antibodies should be carefully monitored for hydrocephalus as part of their routine physical examination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330304     DOI: 10.1002/art.22543

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

Review 1.  Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.

Authors:  Antonio Brucato; Rolando Cimaz; Roberto Caporali; Véronique Ramoni; Jill Buyon
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

2.  2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren's syndrome.

Authors:  Fabiola Reis Oliveira; Valeria Valim; Sandra Gofinet Pasoto; Marilena Leal Mesquita Silvestre Fernandes; Maria Lucia Lemos Lopes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lucia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Libório; Maria Carmen Lopes Ferreira Silva Santos; Leandro Tanure; Juliana DAgostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Samira Tatiyama Miyamoto; Lissiane Karine Noronha Guedes; Alisson Pugliesi; Virginia Fernandes Moça Trevisani
Journal:  Adv Rheumatol       Date:  2021-09-03

3.  Neonatal lupus erythematosus.

Authors:  Kam Lun Hon; Alexander K C Leung
Journal:  Autoimmune Dis       Date:  2012-09-02

4. 

Authors:  Jérôme Coulombe; Julie Barsalou
Journal:  CMAJ       Date:  2021-09-13       Impact factor: 8.262

5.  Neonatal lupus presenting as a butterfly rash.

Authors:  Jerome Coulombe; Julie Barsalou
Journal:  CMAJ       Date:  2021-05-31       Impact factor: 8.262

Review 6.  Methods to quantify soft tissue-based cranial growth and treatment outcomes in children: a systematic review.

Authors:  Sander Brons; Machteld E van Beusichem; Ewald M Bronkhorst; Jos M Draaisma; Stefaan J Bergé; Jan G Schols; Anne Marie Kuijpers-Jagtman
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.